BlackRock Inc. purchased a new position in Schrodinger, Inc. (NASDAQ: SDGR) during the undefined qua

RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing

On August 14, 2026, Schrodinger Inc (SDGR) shares fell 4.8% to $17.58, continuing a trend of volatil

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026, the company granted restri

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on August 12, 2026,

Weave Communications (NYSE: WEAV - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report)

Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch g

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript

Schrodinger NASDAQ: SDGR said second-quarter annual contract value growth accelerated as demand broa

Schrodinger (NASDAQ: SDGR) said second-quarter annual contract value growth accelerated as demand br

Schrodinger, Inc. (SDGR) came out with quarterly earnings of $0.08 per share, beating the Zacks Cons

NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Today Schrödinger announced financial results for the quart

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS t

Schrödinger is challenging the incumbent drug-trial method—physics-simulated molecular design that c

Schrödinger, Inc. (Nasdaq: SDGR) today announced the launch of its early access version of Bunsen, i

NEW YORK--(BUSINESS WIRE)---- $SDGR #BunsenAI--Schrödinger, Inc. today announced the launch of its e

/PRNewswire/ -- For years, the promise of artificial intelligence in drug discovery has been easy to

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its second quarter 2026 fina

Amova Asset Management Americas Inc. boosted its holdings in shares of Schrodinger, Inc. (NASDAQ: SD

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on July 16, 2026, th

The Pentagon just earmarked over $74 billion for drone dominance and counter drone technologies in t

Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de

Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight an

Schrodinger (NASDAQ:SDGR) affirms FY2026 sales outlook from $273.000 million-$293.000 million to $27

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.63) per share which met the analyst conse

Keybanc analyst Brandon Nispel maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers t

UBS analyst Michael Yee maintains Schrodinger (NASDAQ:SDGR) with a Neutral and lowers the price t

Schrodinger (NASDAQ:SDGR) sees FY2026 sales of $273.000 million-$293.000 million vs $301.358 million

Schrodinger (NASDAQ:SDGR) reported quarterly sales of $87.200 million which beat the analyst consens

Schrödinger, Inc. (NASDAQ:SDGR) provided an update on its progress across the business in 2025 and a

TD Cowen analyst Brendan Smith maintains Schrodinger (NASDAQ:SDGR) with a Buy and lowers the pric

Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers

UBS analyst Michael Yee initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and

B of A Securities analyst Michael Ryskin upgrades Schrodinger (NASDAQ:SDGR) from Neutral to Buy a

Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.440 million-$257.460 million to $24

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.57) per share which beat the analyst cons

Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (N

Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers

Goldman Sachs analyst Andrea Newkirk initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutr

-SEC Filing-SEC Filing

Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight an